ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
Position in RPRX — Royalty Pharma plc
CIK 1164508
BOSTON, MA
Position in RPRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$96,438,792
-$31,585,767 QoQ
Shares Held
2,010,398
-39.3% QoQ
Ownership
0.349%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $1,776,833,307 across 48 Biotechnology names. RPRX ranks #7 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
638,950 | $285,316,733 | |
| 2 | INCY |
Incyte Corp
|
2,830,799 | $266,434,801 | |
| 3 | EXEL |
Exelixis, Inc.
|
4,834,625 | $207,357,066 | |
| 4 | GMAB |
Genmab A/S
|
4,975,324 | $133,487,942 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
171,571 | $132,562,617 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,918,149 | $123,969,969 | |
| 7 | RPRX |
Royalty Pharma plc
This page
|
2,010,398 | $96,438,792 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
737,859 | $55,405,832 |
All Filings in RPRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $96,438,792 | 2,010,398 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $128,024,559 | 3,313,265 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $115,795,098 | 3,282,174 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $107,242,574 | 2,976,480 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $42,360,894 | 1,360,774 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $17,088,664 | 669,881 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $39,329,408 | 1,390,223 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $24,788,696 | 940,034 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $26,808,996 | 882,746 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $49,978,739 | 1,779,236 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $53,010,987 | 1,953,242 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $58,842,999 | 1,914,216 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $70,479,183 | 1,956,125 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $98,755,342 | 2,498,870 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $77,202,896 | 1,921,426 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $44,417,572 | 1,056,555 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $23,082,903 | 592,477 | Shares | Defined | 2022-05-13 | |
| 2021-09-30 | $2,144,186 | 59,330 | Shares | Defined | 2021-11-12 | |
| 2021-03-31 | $780,798 | 17,900 | Shares | Defined | 2021-05-14 | |
| 2020-09-30 | $12,388,815 | 294,481 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||